Industry: Chemical & Material
Published Date: 2024-11-12
Pages: 144 Pages
Report ld: 3372691
Request Sample
Customized Report
The global Cannabigerol revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Cannabigerol revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Cannabigerol market, also covers the segmentation data of other regions in regional level and county level.
Cannabigerol, or CBG, is a non-psychoactive cannabinoid that is one of the many chemical compounds found within the cannabis plant. It’s often referred to as the “stem cell” or “mother” of all cannabinoids because it serves as the precursor for the development of other major cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD). CBG is produced in the early stages of the cannabis plant’s growth, and as the plant matures, it undergoes enzymatic changes that convert CBG into other cannabinoids, making it a relatively rare compound in mature cannabis plants.
The global key players of Cannabigerol include Ilesol Pharmaceuticals, Bunyip Hemp, KND Labs, GVB Biopharma, Future Compounds, Red Mesa Science & Refining, LLC, Pharma Works LLC (CanniLabs), WeeDutch, Klersun, LLC, Mile High Labs, etc. The global five biggest players hold a share of % in 2023.
Cannabigerol market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Cannabigerol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Cannabigerol market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Cannabigerol definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Cannabigerol companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Cannabigerol in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cannabigerol sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Cannabigerol Product Introduction
1.2 Global Cannabigerol Outlook 2019 VS 2023 VS 2030
1.2.1 Global Cannabigerol Sales in US$ Million for the Year 2019-2030
1.2.2 Global Cannabigerol Sales in Volume for the Year 2019-2030
1.3 United States Cannabigerol Outlook 2019 VS 2023 VS 2030
1.3.1 United States Cannabigerol Sales in US$ Million for the Year 2019-2030
1.3.2 United States Cannabigerol Sales in Volume for the Year 2019-2030
1.4 Cannabigerol Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Cannabigerol in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Cannabigerol Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Cannabigerol Market Dynamics
1.5.1 Cannabigerol Industry Trends
1.5.2 Cannabigerol Market Drivers
1.5.3 Cannabigerol Market Challenges
1.5.4 Cannabigerol Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Cannabigerol by Type
2.1 Cannabigerol Market by Type
2.1.1 CBG Distillate
2.1.2 CBG lsolate
2.2 Global Cannabigerol Market Size by Type
2.2.1 Global Cannabigerol Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Cannabigerol Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Cannabigerol Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Cannabigerol Market Size by Type
2.3.1 United States Cannabigerol Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Cannabigerol Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Cannabigerol Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Cannabigerol by Application
3.1 Cannabigerol Market by Application
3.1.1 Edibles
3.1.2 Vapes
3.1.3 Pharmaceuticals
3.1.4 Cosmetics
3.2 Global Cannabigerol Market Size by Application
3.2.1 Global Cannabigerol Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Cannabigerol Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Cannabigerol Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Cannabigerol Market Size by Application
3.3.1 United States Cannabigerol Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Cannabigerol Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Cannabigerol Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Cannabigerol Competitor Landscape by Company
4.1 Global Cannabigerol Market Size by Company
4.1.1 Global Key Manufacturers of Cannabigerol, Ranked by Revenue (2023)
4.1.2 Global Cannabigerol Revenue by Manufacturer (2019-2024)
4.1.3 Global Cannabigerol Sales by Manufacturer (2019-2024)
4.1.4 Global Cannabigerol Price by Manufacturer (2019-2024)
4.2 Global Cannabigerol Concentration Ratio (CR)
4.2.1 Cannabigerol Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cannabigerol in 2023
4.2.3 Global Cannabigerol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Cannabigerol, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Cannabigerol, Product Offered and Application
4.5 Global Key Manufacturers of Cannabigerol, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Cannabigerol Market Size by Company
4.7.1 Key Players of Cannabigerol in United States, Ranked by Revenue (2023)
4.7.2 United States Cannabigerol Revenue by Players (2019-2024)
4.7.3 United States Cannabigerol Sales by Players (2019-2024)
5 Global Cannabigerol Market Size by Region
5.1 Global Cannabigerol Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Cannabigerol Market Size in Volume by Region (2019-2030)
5.2.1 Global Cannabigerol Sales in Volume by Region: 2019-2024
5.2.2 Global Cannabigerol Sales in Volume Forecast by Region (2025-2030)
5.3 Global Cannabigerol Market Size in Value by Region (2019-2030)
5.3.1 Global Cannabigerol Sales in Value by Region: 2019-2024
5.3.2 Global Cannabigerol Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Cannabigerol Market Size YoY Growth 2019-2030
6.2 Americas Cannabigerol Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Cannabigerol Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Cannabigerol Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Cannabigerol Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Cannabigerol Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Cannabigerol Market Size YoY Growth 2019-2030
7.2 EMEA Cannabigerol Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Cannabigerol Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Cannabigerol Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Cannabigerol Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Cannabigerol Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Cannabigerol Market Size YoY Growth 2019-2030
8.2 China Cannabigerol Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Cannabigerol Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Cannabigerol Market Size YoY Growth 2019-2030
9.2 APAC Cannabigerol Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Cannabigerol Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Cannabigerol Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Cannabigerol Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Cannabigerol Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Ilesol Pharmaceuticals
10.1.1 Ilesol Pharmaceuticals Company Information
10.1.2 Ilesol Pharmaceuticals Description and Business Overview
10.1.3 Ilesol Pharmaceuticals Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Ilesol Pharmaceuticals Cannabigerol Products Offered
10.1.5 Ilesol Pharmaceuticals Recent Development
10.2 Bunyip Hemp
10.2.1 Bunyip Hemp Company Information
10.2.2 Bunyip Hemp Description and Business Overview
10.2.3 Bunyip Hemp Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Bunyip Hemp Cannabigerol Products Offered
10.2.5 Bunyip Hemp Recent Development
10.3 KND Labs
10.3.1 KND Labs Company Information
10.3.2 KND Labs Description and Business Overview
10.3.3 KND Labs Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.3.4 KND Labs Cannabigerol Products Offered
10.3.5 KND Labs Recent Development
10.4 GVB Biopharma
10.4.1 GVB Biopharma Company Information
10.4.2 GVB Biopharma Description and Business Overview
10.4.3 GVB Biopharma Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.4.4 GVB Biopharma Cannabigerol Products Offered
10.4.5 GVB Biopharma Recent Development
10.5 Future Compounds
10.5.1 Future Compounds Company Information
10.5.2 Future Compounds Description and Business Overview
10.5.3 Future Compounds Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Future Compounds Cannabigerol Products Offered
10.5.5 Future Compounds Recent Development
10.6 Red Mesa Science & Refining, LLC
10.6.1 Red Mesa Science & Refining, LLC Company Information
10.6.2 Red Mesa Science & Refining, LLC Description and Business Overview
10.6.3 Red Mesa Science & Refining, LLC Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.6.4 Red Mesa Science & Refining, LLC Cannabigerol Products Offered
10.6.5 Red Mesa Science & Refining, LLC Recent Development
10.7 Pharma Works LLC (CanniLabs)
10.7.1 Pharma Works LLC (CanniLabs) Company Information
10.7.2 Pharma Works LLC (CanniLabs) Description and Business Overview
10.7.3 Pharma Works LLC (CanniLabs) Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.7.4 Pharma Works LLC (CanniLabs) Cannabigerol Products Offered
10.7.5 Pharma Works LLC (CanniLabs) Recent Development
10.8 WeeDutch
10.8.1 WeeDutch Company Information
10.8.2 WeeDutch Description and Business Overview
10.8.3 WeeDutch Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.8.4 WeeDutch Cannabigerol Products Offered
10.8.5 WeeDutch Recent Development
10.9 Klersun, LLC
10.9.1 Klersun, LLC Company Information
10.9.2 Klersun, LLC Description and Business Overview
10.9.3 Klersun, LLC Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Klersun, LLC Cannabigerol Products Offered
10.9.5 Klersun, LLC Recent Development
10.10 Mile High Labs
10.10.1 Mile High Labs Company Information
10.10.2 Mile High Labs Description and Business Overview
10.10.3 Mile High Labs Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Mile High Labs Cannabigerol Products Offered
10.10.5 Mile High Labs Recent Development
10.11 Essentia Pura
10.11.1 Essentia Pura Company Information
10.11.2 Essentia Pura Description and Business Overview
10.11.3 Essentia Pura Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.11.4 Essentia Pura Cannabigerol Products Offered
10.11.5 Essentia Pura Recent Development
10.12 Northeast Heritage Limited
10.12.1 Northeast Heritage Limited Company Information
10.12.2 Northeast Heritage Limited Description and Business Overview
10.12.3 Northeast Heritage Limited Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.12.4 Northeast Heritage Limited Cannabigerol Products Offered
10.12.5 Northeast Heritage Limited Recent Development
10.13 Blue Sky
10.13.1 Blue Sky Company Information
10.13.2 Blue Sky Description and Business Overview
10.13.3 Blue Sky Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.13.4 Blue Sky Cannabigerol Products Offered
10.13.5 Blue Sky Recent Development
10.14 Verus Extracts
10.14.1 Verus Extracts Company Information
10.14.2 Verus Extracts Description and Business Overview
10.14.3 Verus Extracts Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.14.4 Verus Extracts Cannabigerol Products Offered
10.14.5 Verus Extracts Recent Development
10.15 EcoGen Biosciences
10.15.1 EcoGen Biosciences Company Information
10.15.2 EcoGen Biosciences Description and Business Overview
10.15.3 EcoGen Biosciences Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.15.4 EcoGen Biosciences Cannabigerol Products Offered
10.15.5 EcoGen Biosciences Recent Development
10.16 clēēn:tech
10.16.1 clēēn:tech Company Information
10.16.2 clēēn:tech Description and Business Overview
10.16.3 clēēn:tech Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.16.4 clēēn:tech Cannabigerol Products Offered
10.16.5 clēēn:tech Recent Development
10.17 Synceres
10.17.1 Synceres Company Information
10.17.2 Synceres Description and Business Overview
10.17.3 Synceres Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.17.4 Synceres Cannabigerol Products Offered
10.17.5 Synceres Recent Development
10.18 Tilray
10.18.1 Tilray Company Information
10.18.2 Tilray Description and Business Overview
10.18.3 Tilray Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.18.4 Tilray Cannabigerol Products Offered
10.18.5 Tilray Recent Development
10.19 Charlotte’s web
10.19.1 Charlotte’s web Company Information
10.19.2 Charlotte’s web Description and Business Overview
10.19.3 Charlotte’s web Cannabigerol Sales, Revenue and Gross Margin (2019-2024)
10.19.4 Charlotte’s web Cannabigerol Products Offered
10.19.5 Charlotte’s web Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Cannabigerol Industry Chain Analysis
11.2 Cannabigerol Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Cannabigerol Production Mode & Process
11.4 Cannabigerol Sales and Marketing
11.4.1 Cannabigerol Sales Channels
11.4.2 Cannabigerol Distributors
11.5 Cannabigerol Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 292 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 178
USD 4900.00
(Single User License)
The global Cannabigerol market size was US$ 164 million in 2025 and is forecast to reach a readjusted size of US$ 292 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 107
USD 4250.00
(Single User License)
The global Cannabigerol market was valued at US$ 164 million in 2025 and is anticipated to reach US$ 292 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 147
USD 2900.00
(Single User License)
The global market for Cannabigerol was estimated to be worth US$ 164 million in 2025 and is projected to reach US$ 292 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 144
USD 3950.00
(Single User License)
The global Cannabigerol market is projected to grow from US$ 157 million in 2024 to US$ 271 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 179
USD 4900.00
(Single User License)
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 271 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published Date: 2025-06-28
Pages: 180
USD 4900.00
(Single User License)
The global Cannabigerol market size was US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 108
USD 4250.00
(Single User License)
The global market for Cannabigerol was estimated to be worth US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 146
USD 3950.00
(Single User License)
The global market for Cannabigerol was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 271 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-06-28
Pages: 107
USD 2900.00
(Single User License)
The global Cannabigerol market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-11-12
Pages: 176
USD 4900.00
(Single User License)
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 292 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 178
The global Cannabigerol market size was US$ 164 million in 2025 and is forecast to reach a readjusted size of US$ 292 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 107
The global Cannabigerol market was valued at US$ 164 million in 2025 and is anticipated to reach US$ 292 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 147
The global market for Cannabigerol was estimated to be worth US$ 164 million in 2025 and is projected to reach US$ 292 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 144
The global Cannabigerol market is projected to grow from US$ 157 million in 2024 to US$ 271 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 179
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 271 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published: 2025-06-28
Pages: 180
The global Cannabigerol market size was US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 108
The global market for Cannabigerol was estimated to be worth US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 146
The global market for Cannabigerol was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 271 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-06-28
Pages: 107
The global Cannabigerol market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-11-12
Pages: 176
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now